Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Total Current Liabilities (2016 - 2025)

iBio (IBIO) has disclosed Total Current Liabilities for 15 consecutive years, with $5.9 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 25.31% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, up 25.31% year-over-year, with the annual reading at $6.1 million for FY2025, 59.01% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $5.9 million at iBio, down from $6.0 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $32.2 million in Q3 2022, with the low at $3.5 million in Q3 2024.
  • Average Total Current Liabilities over 5 years is $13.6 million, with a median of $8.2 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities skyrocketed 358.03% in 2022, then plummeted 83.25% in 2024.
  • Over 5 years, Total Current Liabilities stood at $8.3 million in 2021, then soared by 232.79% to $27.8 million in 2022, then dropped by 22.4% to $21.6 million in 2023, then crashed by 78.15% to $4.7 million in 2024, then grew by 25.31% to $5.9 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $5.9 million, $6.0 million, and $6.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.